Last October was an FDA approval. This October is a $68 million fundraising round. Next year, maybe a drug launch.
Orasis Pharmaceuticals …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SAN DIEGO — Administering emicizumab (Hemlibra) to previously untreated or minimally treated infants with severe hemophilia A without factor VIII inhibitors is effective and safe,
For-profit nursing schools often market their programs to people working in low-level jobs, people looking to improve their life circumstances. Most promise a flexible, expedited
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture